secwatch.observer — SEC 8-K summary
======================================

Issuer:     ExcelFin Acquisition Corp. (—)
CIK:        0001852749
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001104659-24-033517
Event type: m_and_a
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baird Medical amends SPAC merger terms; revenue slumped 29% below projections
-----------------------------------------------------------------------------

- 30% of Betters Medical's shares (8.8M PubCo shares) subject to earnout at $12.50 VWAP over 20 of 30 days.
- Minimum cash condition of $15M waived, removing a key closing condition.
- Maximum extension date moved from June 25, 2024 to May 25, 2024.
- Baird Medical's 2023 revenue came in 29% below its prior projections due to inventory buildup and Class III re-registration delays.
- Baird Medical holds Class III certificate for MWA devices; only four entities in China have one.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1852749/000110465924033517/0001104659-24-033517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1852749/000110465924033517/tm244137d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-033517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer